137 F.2d 252 | D.C. Cir. | 1943
This is an appeal from a judgment of the District Court, dismissing appellants’ complaint in a proceeding under R.S. § 4915
The District Court made findings, among others, as follows “[11] Plaintiffs have not established that honey and vitamin D coact or cooperate in any unusual or unexpected manner, and particularly have not proved that the result obtained from feeding a mixture of vitamin D and honey are more than the additive effect obtainable by feeding honey and vitamin D separately. [12] It was not invention to add vitamin D to honey or to a food product containing honey, and it particularly was not invention to add a vitamin D concentrate to honey or to a food product containing honey, whether it be a vitamin D .concentrate in the form of an alcoholic extract, or an oil concentrate of vitamin D emulsified in the honey, or finely divided crystals of vitamin D dispersed in the honey. [13] If the mixture of vitamin D and honey disclosed by the patent to Bresnick, No. 2,007,108, or the mixture of honey and butter containing vitamin D disclosed in the patent to Rasky, No. 1,892,902, when used as a food would have an effect upon calcium retention in the human body, the discovery of that fact would not be an invention.” The Court concluded that the claims were not patentable.
The evidence revealed by the record in support of the application is not convincing. The Patent Office Examiner concluded, after examining the data submitted by appellants, that it failed to support their conclusions; that vitamin D has a well recognized function of controlling calcium metabolism, being the outstanding agent, in this respect, for preventing rickets; that in appellants’ combination the “vitamin appears to function only in its known capacity; and the honey, seemingly, supplies only its individual values.” The Examiner analysed the experimental data upon which appellants relied and showed its inconclusive character. The Board of Appeals reached the same conclusion; and decided, also, that the claims were not substantially distinguishable over Bresnick’s disclosure concerning honey and fish-liver oils. The evidence in the District Court was no more conclusive. The tests upon which the appellant relied were not calculated, for example, to reveal what difference, if any, would result from feeding honey and vitamin D separately, instead of together. Moreover, the small number of infants used in the experiments, the varying results secured from using honey, as compared with other sugars, the biological differences in the infants, the assimilability of different sugars by different infants; these and many other factors, which should have
While the results obtained from these tentative experiments were perhaps sufficient to justify appellants’ expert in saying: “We know that we can not make him [an infant] grow if we have certain milks, such as cows’ milk; so we put certain sugars into the milk; and one of these that we are advocating is honey”; [Italics supplied] it is quite a different matter to contend that a new food product has been developed, so different, so unusual, or so unexpected in character, as to rise to the dignity of invention.
Affirmed.
35 U.S.C.A. § 63.
Berlin Mills Co. v. Procter & Gamble Co., 254 U.S. 156, 166, 41 S.Ct. 75, 65 L.Ed. 196; Minnesota Mining & Mfg. Co. v. Coe, 69 App.D.C. 217, 99 F.2d 986, 990, and authorities there cited.